MeiraGTx Holdings PLC (MGTX)
4.18
-0.03
(-0.71%)
USD |
NASDAQ |
Jul 01, 10:24
MeiraGTx Holdings Enterprise Value: 223.92M for June 28, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 28, 2024 | 223.92M |
| June 27, 2024 | 225.20M |
| June 26, 2024 | 223.92M |
| June 25, 2024 | 223.92M |
| June 24, 2024 | 227.13M |
| June 21, 2024 | 236.13M |
| June 20, 2024 | 230.35M |
| June 18, 2024 | 227.77M |
| June 17, 2024 | 235.49M |
| June 14, 2024 | 241.92M |
| June 13, 2024 | 249.64M |
| June 12, 2024 | 254.78M |
| June 11, 2024 | 262.50M |
| June 10, 2024 | 261.86M |
| June 07, 2024 | 259.93M |
| June 06, 2024 | 266.36M |
| June 05, 2024 | 273.43M |
| June 04, 2024 | 269.57M |
| June 03, 2024 | 270.86M |
| May 31, 2024 | 268.29M |
| May 30, 2024 | 274.07M |
| May 29, 2024 | 274.72M |
| May 28, 2024 | 283.72M |
| May 24, 2024 | 293.05M |
| May 23, 2024 | 283.72M |
| Date | Value |
|---|---|
| May 22, 2024 | 317.16M |
| May 21, 2024 | 306.87M |
| May 20, 2024 | 309.44M |
| May 17, 2024 | 320.38M |
| May 16, 2024 | 318.45M |
| May 15, 2024 | 308.80M |
| May 14, 2024 | 289.51M |
| May 13, 2024 | 283.72M |
| May 10, 2024 | 279.22M |
| May 09, 2024 | 281.15M |
| May 08, 2024 | 283.72M |
| May 07, 2024 | 299.15M |
| May 06, 2024 | 278.90M |
| May 03, 2024 | 274.72M |
| May 02, 2024 | 274.07M |
| May 01, 2024 | 274.07M |
| April 30, 2024 | 267.00M |
| April 29, 2024 | 268.93M |
| April 26, 2024 | 261.86M |
| April 25, 2024 | 256.07M |
| April 24, 2024 | 265.72M |
| April 23, 2024 | 270.22M |
| April 22, 2024 | 276.00M |
| April 19, 2024 | 280.51M |
| April 18, 2024 | 275.36M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
115.54M
Minimum
Mar 16 2020
919.89M
Maximum
Dec 31 2021
391.60M
Average
352.46M
Median
Enterprise Value Benchmarks
| Regeneron Pharmaceuticals Inc | 107.29B |
| CEL-SCI Corp | 57.52M |
| AIM ImmunoTech Inc | 11.43M |
| IGC Pharma Inc | 31.75M |
| NovaBay Pharmaceuticals Inc | 3.058M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -20.44M |
| Revenue (Quarterly) | 0.697M |
| Total Expenses (Quarterly) | 47.47M |
| EPS Diluted (Quarterly) | -0.32 |
| Profit Margin (Quarterly) | -2.93K% |
| Earnings Yield | -27.99% |
| Normalized Earnings Yield | -56.77 |